NCT03516916

Brief Summary

The formation of a colostomy following surgery for rectal cancer changes body image, challenges patient practical skills and threatens quality of life. As the oncological results have improved over the last decades the number of survivors from rectal cancer who have to adjust to a cancer free life in their own homes is increasing. To enable the identification of the patients with stoma-related reduced health-related Quality of life (HRQoL) in a quick and reliable way we recently developed the Colostomy Impact Score (CI-score) comprising 7 items of stoma related factors with significant impact on HRQoL. The purpose of the present project is to perform an international validation of the CI-score and to demonstrate its applicability. The construct validity of the CI-score will be studied internationally on crosssectional cohorts of patients with permanent colostomy after abdominoperineal excision (APE) or Hartmann's procedure in Denmark, Sweden, Spain, the Netherlands, United Kingdom, Turkey, Brazil, Egypt, Russia, Lithuania, Israel, Portugal, South Africa, Australia and China. This will be done by testing the CI-score against five anchor questions stoma impact on HRQoL, the 5 Level version og the EuroQol measuer (EQ-5D-5L) and version 3.0 of the Quality of Life Questionnaire from the European Organisation for Research and Treatment of Cancer (EORTC QLQ C30 questionnaire v3.0). The impact of the challenges related to having a stoma may vary with different demographic, socioeconomic and cultural factors. Supplementary data on stoma care, demographics and socioeconomic status will be gathered to study the impact of patient-related factors and cultural differences on HRQoL in rectal cancer survivors with an ostomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,750

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 7, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

November 17, 2020

Status Verified

November 1, 2020

Enrollment Period

10 months

First QC Date

April 24, 2018

Last Update Submit

November 14, 2020

Conditions

Keywords

Rectal cancer, HRQoL, Stoma, Colostomy, Patient reported outcome measure (PROM)

Outcome Measures

Primary Outcomes (2)

  • Validity of the Colostomy Impact Score

    Description of sensitivity, specificity and construct validity (hypothesis testing) of the Colostomy Impact Score.

    The end of 2018

  • Impact of demographic, socioeconomic and religious factors on HRQoL in rectal cancer survivors with a colostomy

    Comparing HRQoL between sexes, age groups and different socioeconomic and religious groups and by country.

    The end of 2018

Study Arms (15)

Australia

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Brazil

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

China

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Denmark

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Egypt

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Israel

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Lithuania

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

the Netherlands

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Portugal

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Russia

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

South Africa

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Spain

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Sweden

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Turkey

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

the United Kingdom

Patients with a permanent colostomy after curative surgery for rectal cancer

Other: Questionnaires on HRQoL and sociodemography

Interventions

All patients are asked to answer a panel of questionnaires to test validity and reliability of the Colostomy Impact Score.

AustraliaBrazilChinaDenmarkEgyptIsraelLithuaniaPortugalRussiaSouth AfricaSpainSwedenTurkeythe Netherlandsthe United Kingdom

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with a permanent colostomy after curative intended surgery for rectal cancer. Time since surgery must be more than 1 year. In some countries the cohort will be extracted from a national or institutional registry representing all operated patients in a certain time period that allows for inclusion of 250 patients. In countries whithout such registries convenient inclusion from the surgical department or stoma clinic.

You may qualify if:

  • Curative intended Hartmann's procedure or abdominal perineal excision \>12 months ago for carcinoma of the rectum
  • Permanent colostomy

You may not qualify if:

  • Age \< 18 years
  • Recurrence of cancer
  • Mental dementia
  • Unable to understand the actual language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, Aarhus University Hospital

Aarhus, Aarhus C, 8000, Denmark

Location

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Helle Ø Kristensen, MD

    Danish Cancer Society Centre for Research on Survivorship and Late Adverse Effects After Cancer in the Pelvic Organs, Department of Surgery, Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

April 24, 2018

First Posted

May 7, 2018

Study Start

February 1, 2019

Primary Completion

December 1, 2019

Study Completion

December 31, 2020

Last Updated

November 17, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations